DePuy Synthes Archives - Medical Design Sourcing

The world’s first whole-eye and partial-face transplant used DePuy Synthes tech

Surgeons used pre-surgical planning software to develop transplant guides for the donor (left) and recipient (right). [Image courtesy of NYU Lagone Health]

Surgeons used DePuy Synthes technology for the world’s first whole-eye and partial-face transplant.

The 21-hour procedure was performed by a 16-person surgical team and 80-person operating room team on Aaron James, a military vet who lost his left eye and much of his face in a high-voltage power accident while working as a utility lineman.

Led by NYU Langone Health’s Dr. Eduardo Rodriguez, the team gave James a donor’s eye and part of their face, including the orbital bones, surrounding eye tissues and the optical nerve, left upper and lower eyelids, left eyebrow, nose, upper and lower lips, and underlying skull, cheek, nasal and chin bone segments, including muscles, blood vessels and nerves.

James spent 17 days in the intens…

DePuy Synthes collab aids in whole-eye, partial-face transplant

The surgery lasted approximately 21 hours and included a team of more than 140 surgeons, nurses, and other healthcare professionals, led by Dr. Eduardo D. Rodriguez. [Image courtesy of Joe Carotta/NYU Langone Staff]With help from J&J’s DePuy Synthes, a team at NYU Langone Health performed the world’s first whole-eye and partial-face transplant.

A 46-year-old military veteran from Arkansas who survived a work-related, high-voltage electrical accident underwent the procedure. He had his entire left eye and a portion of his face transplanted from a single donor.

According to NYU Langone Health, it remains unknown if the patient will ever regain sight. However, the transplanted left eye has shown “remarkable signs of health, including direct blood flow to the retina.” NYU Langone says this opens new possibilities for future advancements in vision therapies and related medical fields.

The hospital said its collaboration with DePuy Syn…

J&J’s DePuy is laying off 67 workers in Colorado

Johnson & Johnson’s (NYSE: JNJ) + DePuy Spine issued a WARN letter confirming 67 layoffs at a facility in Monument, Colorado.

The company issued the letter pursuant to the Worker Adjustment and Retraining Notification (WARN) Act. It decided to eliminate positions permanently at the facility located at 1101 Synthes Avenue, Monument, Colorado.

DePuy’s letter said the action comes as a result of a business decision. The company elected to permanently discontinue manufacturing, quality and distribution activities at the location. Employee separation comes over the course of a 14-day window. The state received the WARN letter on Oct. 30 and it says layoffs begin on Dec. 29, 2023.

Jobs affected by the layoffs include assembly/packaging, business solutions, facilities and manufacturing/production positions. The largest amount of employees affected — 41 — hold material/handling/distribution jobs. The lay…

FDA clears DePuy Synthes TriLeap plating system for foot and ankle surgeries

The TriLeap lower extremity anatomic plating system [Image courtesy of DePuy Synthes]DePuy Synthes, the orthopedic device business of Johnson & Johnson (NYSE: JNJ) + , has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system.

The company said it designed the TriLeap system to address the intricate needs of orthopedic surgeons and foot and ankle specialists.

As conditions like bunions become more prevalent —with Cleveland Clinic reporting that one in three U.S. residents are grappling with the disorder—elective foot surgeries are witnessing a surge. Plating systems like TriLeap play an important role in these surgeries, functioning as implants that stabilize the bones during procedures such as bunionectomies and osteotomies.

TriLeap offers a wide range of plate options tailored for various procedures and screw diameters, according to DePuy Synthes. Its instruments can be used during th…

J&J’s DePuy Synthes wins FDA clearance for TriAltis tech

The TriAltis Spine system. [Image courtesy of DePuy Synthes]Johnson & Johnson MedTech announced today that its DePuy Synthes unit won FDA 510(k) clearance for two TriAltis technologies.

The FDA cleared the company’s TriAltis Spine system and the TriAltis navigation-enabled instruments. TriAltis Spine is a next-generation posterior thoracolumbar pedicle screw system. It offers a comprehensive implant portfolio and advanced instrumentation for integration with enabling technology.

DePuy Synthes’ TriAltis navigation-enabled instruments include drills, taps and screwdrivers. These offer manual operation or power operation for navigated and non-navigated use.

The company said combining its implants with a digital ecosystem can address unmet clinical needs. Its TriAltis Spine system could help surgeons achieve more consistent outcomes in treating complex spine conditions, too. That includes degenerative tumor, trauma and deformity pathologies.

…

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]

Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker and Zimmer Biomet both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product launches between this year and the end of 2025, the …

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker] Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker (NYSE: SYK) + and Zimmer Biomet (NYSE: ZBH) + both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product …

Former DePuy Synthes sales rep accused of defrauding Boston area hospital

[Image from Pixabay]Federal prosecutors claim a former DePuy Synthes sales representative defrauded an undisclosed Boston area hospital, with hundreds of thousands of dollars worth of spine products involved.

According to a federal grand jury indictment announced this week in Massachusetts, Matthew Capobianco falsely represented on usage forms that more—and more expensive—Johnson & Johnson DePuy products were used during spine surgeries than were actually used. The falsification allegedly took place from January 2016 through June 2017. It enabled Capobianco to boost his sales numbers, increase his compensation, and attain higher rankings within DePuy’s sales organization, according to the indictment.

A news release from the U.S. Attorney’s Office in Massachusetts summarizes another accusation made against Capobianco in the indictment:

“It is further alleged that, in late 2016, Capobianco instructed a subordinate DePuy sales representative to…

DePuy Synthes to pay $9.75M to resolve surgeon kickbacks case

Johnson & Johnson’s DePuy Synthes has settled with federal prosecutors over allegations that it provided a Massachusetts-based surgeon with $100,000 worth of free products to win business.

As part of the $9.75 million settlement agreement, DePuy Synthes admitted that it provided free cages, rods, screws, plates and modular access and retraction systems to the surgeon from at least July 2013 through February 2018, the U.S. Attorney in Massachusetts announced in a news release today.

The surgeon used the ortho devices during more than 20 procedures in Bahrain, Saudi Arabia, Kuwait, Lebanon, the United Arab Emirates and Qatar. The DePuy products appear to have been advantageous because they were not always available.

Federal prosecutors claimed that the free products provided the surgeon an inducement to also use DePuy Synthes products during procedures in Massachusetts involving Medicare and Med…

Why are so many medical device companies making big investments in Ireland?

[Image from Ainars Djatlevskis on Unsplash] The foreign direct investment agency for Ireland has some of the biggest names in medtech investing in the country.

Within recent years, a number of major medtech companies celebrated anniversaries. Abbott’s was 70 years, Medtronic’s was 40 and Boston Scientific’s was 25.

That’s how long those companies have operated in Ireland.

Gerard Kilcommins, Medtronic VP of global manufacturing, vascular therapies and implants and country director in Ireland, said in a report earlier this year that its 40-year anniversary represents “an important milestone” in the company’s history.

“Our sites in Ireland have played a significant role in Medtronic’s evolution from medical device manufacturer to a global leader in healthcare technology,” Kilcommins said in July.

Each of those three companies, plus many more big names in medtech, choose Ireland for a broad range of inve…

Depuy Synthes wins FDA clearance for Teligen system

Johnson & Johnson MedTech’s DePuy Synthes this week announced it received FDA 510(k) clearance for its Teligen technology platform for spinal procedures.

Teligen is an integrated technology platform that enables minimally invasive surgical transforaminal lumber interbody fusion (MIS-TLIF) procedures using digital tools for visualization and access. The system has a tower with a camera control system, a VueLIF-T procedure kit with a disposable HD camera, a Teligen clear discectomy device and patient-based disposable ports.

DePuy Synthes’ new system integrates the company’s Unleash bundle of implant solutions that streamline the main stages in MIS-TLIF.

TLIF is a common posterior surgical approach used for treating patients with persistent pain in their lower backs and have spinal instability and fail to respond to noninvasive management. According to the company, TLIF can present clinical challenges like greater soft tissue disruptio…

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …